Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — Results from an international trial demonstrate that ranolazine was safe and effective for ...

Please provide your email address to receive an email when new articles are posted on . Published data from the HARMONY trial confirm a previous report that moderate-dose ranolazine plus reduced-dose ...

Ranolazine reduced episodes of stable angina in diabetes patients already receiving one or two antianginal drugs and led to less use of sublingual nitroglycerin, and the benefits appeared more ...

According to the results of a study reanalyzing data obtained from an FDA review, , ranolazine potentiates the effects associated with ACE inhibitors, as well as angiotensin receptor blockers.

Vienna, Austria - New data presented this week has shown that the novel antianginal agent ranolazine (Ranexa, CV Therapeutics, Palo Alto, CA), an inhibitor of the late phase of the sodium current, is ...

Routine treatment with ranolazine does not reduce the composite rate of ischemia-driven revascularization or hospitalization in patients with a history of chronic angina who have incomplete ...

Review the side-effects of Ranolazine as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

(HealthDay News) — For patients with type 2 diabetes on background glimepiride therapy, but not metformin, addition of ranolazine is associated with a significant reduction in hemoglobin A1c (HbA1c), ...

Gilead Sciences and the Cardiovascular Research Foundation (CRF) have commenced RIVER-PCI (Ranolazine for Incomplete VEssel Revascularization post-PCI), Phase 3 clinical trial to assess ranolazine in ...

The results of TERISA, a randomized, double-blind trial in which the effect of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina was examined, were reported at the ACC ...

Despite the availability of a number of antianginal agents, many patients with stable coronary artery disease (CAD) have persistent angina. Even following CABG surgery or percutaneous coronary ...

Ranolazine (Ranx) is an anti-anginal compound, prescribed for chest pain either alone or combined with other medication. The information provided on this page is intended to serve as a comprehensive ...